Warning letter
Farouk Systems, Inc.: warning letter of Jul 24, 2002
FDA warning letter UCM145026 · Dallas District Office
Key facts
| Reference number | UCM145026 |
|---|---|
| Company | Farouk Systems, Inc. |
| Subject | New Drug/Labeling/Misbranded |
| Issue date | Jul 24, 2002 |
| Posted date | Jul 24, 2002 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 358.701, 310.527, 358.750(b) |
| Country | 3 |
| Inspection city | Houston |
| Inspection ZIP | 77090-5905 |
| Inspection start date | May 28, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: